ABU DHABI / GULF TIME The highly anticipated Middle East Asset Integrity Management Expo (AIMCS ...
Read More »Akorn slumps after Fresenius abandons $4.3bn takeover bid
Bloomberg Akorn Inc. shares lost about a third of their value after Fresenius SE walked away from a pending $4.3 billion acquisition of the US maker of generic cancer drugs in response to a probe that found problems with its product-development practices. The German company said its outside experts found “material breaches†of US Food and Drug Administration standards while ...
Read More »